Cancer-induced hypercalcemia.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Anticancer Research

• Publication date

  2009-05-01

• Fields of study

  Medicine

• Identifiers
  PMID 19443365
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hypercalcemia of malignancy

  2017cited by this paper
• Medical treatment of malignancy-associated hypercalcemia.

  2008cited by this paper
• Critical review: updated recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaw in cancer patients--May 2006.

  2007cited by this paper
• Malignancy-related hypercalcemia developing on a bisphosphonate but responding to calcitonin.

  2007cited by this paper
• A study of the biological receptor activator of nuclear factor-kappaB ligand inhibitor, denosumab, in patients with multiple myeloma or bone metastases from breast cancer.

  2006cited by this paper
• Denosumab in postmenopausal women with low bone mineral density.

  2006cited by this paper
• Randomized, Double‐Blind, Phase II Trial of Gallium Nitrate Compared with Pamidronate for Acute Control of Cancer‐Related Hypercalcemia

  2006cited by this paper
• Parathyroid cancer: etiology, clinical presentation and treatment.

  2006cited by this paper
• PCNA-LI, Ki-67 Immunostaining, p53 Activity and Histopathological Variables in Predicting the Clinical Outcome in Patients with Parathyroid Carcinoma

  2006cited by this paper
• Clinical practice. Hypercalcemia associated with cancer.

  2005cited by this paper
• Bisphosphonate treatment does not affect serum levels of osteoprotegerin and RANKL in hypercalcemic cancer patients.

  2005cited by this paper
• The inhibition of RANKL causes greater suppression of bone resorption and hypercalcemia compared with bisphosphonates in two models of humoral hypercalcemia of malignancy.

  2005cited by this paper
• Hypercalcemia Associated with Cancer

  2005cited by this paper
• Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL–RANK signaling system

  2005cited by this paper
• Increased Renal Calcium Reabsorption by Parathyroid Hormone–Related Protein Is a Causative Factor in the Development of Humoral Hypercalcemia of Malignancy Refractory to Osteoclastic Bone Resorption Inhibitors

  2005cited by this paper
• Chapter 61 – Hypercalcemia of Malignancy and Parathyroid Hormone—Related Protein

  2005cited by this paper
• Technetium-99m sestamibi scintigraphy and helical CT together in patients with primary hyperparathyroidism: a prospective clinical study.

  2004cited by this paper
• Treating cancer-related hypercalcemia with gallium nitrate.

  2004cited by this paper
• Thousands of families to sue over retained organs

  2004cited by this paper
• A Single‐Dose Placebo‐Controlled Study of AMG 162, a Fully Human Monoclonal Antibody to RANKL, in Postmenopausal Women

  2004cited by this paper
• The antineoplastic role of bisphosphonates: from basic research to clinical evidence.

  2003cited by this paper
• Medical Management of Hypercalcemia

  2003cited by this paper
• Developmental regulation of the growth plate

  2003cited by this paper
• Efficacy and safety of ibandronate in the treatment of hypercalcemia of malignancy: a randomized multicentric comparison to pamidronate

  2003cited by this paper
• New insights into the molecular mechanisms of action of bisphosphonates.

  2003cited by this paper
• The effects of gallium nitrate on bone resorption.

  2003cited by this paper
• Metastasis movies, macrophages, molecules and more

  2003cited by this paper
• Treatment of malignancy-associated hypercalcemia and cachexia with humanized anti-parathyroid hormone-related protein antibody.

  2003cited by this paper
• Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

  2003cited by this paper
• Apoptosis: life through planned cellular death regulating mechanisms, control systems, and relations with thyroid diseases.

  2002cited by this paper
• Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy: a pooled analysis of two randomized, controlled clinical trials.

  2001cited by this paper
• The role of bisphosphonates in breast cancer: The present and future role of bisphosphonates in the management of patients with breast cancer

  2001cited by this paper
• A Dose‐Finding Study of Zoledronate in Hypercalcemic Cancer Patients

  1999cited by this paper
• Bisphosphonates: mechanisms of action

  1998cited by this paper
• Evaluation of new bone resorption markers in a randomized comparison of pamidronate or clodronate for hypercalcemia of malignancy.

  1997cited by this paper
• Investigation of hypocalcaemia

  1995cited by this paper
• Significance of plasma PTH‐rp in patients with hypercalcemia of malignancy treated with bisphosphonate

  1994cited by this paper
• Effect of salmon calcitonin and etidronate on hypercalcemia of malignancy

  1992cited by this paper
• Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: a prospective randomized crossover trial.

  1992cited by this paper
• Mechanisms of cancer-induced hypercalcemia.

  1992cited by this paper
• Original article: Plicamycin and pamidronate in symptomatic tumor-related hypercalcemia: A prospective randomized crossover trial

  1992cited by this paper
• [Hypercalcemia in malignancy].

  1991cited by this paper

• SAT-763 A Case of Parathyroid Crisis with EKG Changes Mimicking ST Elevation Myocardial Infarct

  2025cites this paper
• Assessing the Impact of Comorbid Hypercalcemia on Inpatient Outcomes of Patients With Diffuse Large B-cell Lymphoma During Admission for Chemotherapy

  2024cites this paper
• Malignant Hypercalcemia Due to the Ectopic Production of Calcitriol by an Abdominal Liposarcoma

  2023cites this paper
• Commentary on the endocrine society clinical practice guideline on the "treatment of hypercalcemia of malignancy in adults".

  2023cites this paper
• Treatment of Hypercalcemia of Malignancy in Adults: An Endocrine Society Clinical Practice Guideline.

  2022cites this paper
• A Systematic Review Supporting the Endocrine Society Clinical Practice Guideline on the Treatment of Hypercalcemia of Malignancy in Adults.

  2022cites this paper
• Identification of MAGEC2/CT10 as a High Calcium-Inducible Gene in Triple-Negative Breast Cancer

  2022cites this paper
• Seizures Associated With Bone Density Conservation Agents

  2022cites this paper
• Entwicklung molekularer Sonden für die hyperpolarisierte NMR‐Bildgebung im biologischen Bereich

  2021cites this paper
• Vitamin D poisoning; hypercalcemia in a case with richter transformation

  2021cites this paper
• Treatment of Hypercalcemia of Malignancy.

  2021cites this paper
• "The use of bisphosphonates to treat skeletal complications in solid tumours".

  2021cites this paper
• Oncological Emergencies from Pathophysiology and Diagnosis to Treatment: A Narrative Review

  2020cites this paper
• Hypercalcaemia of malignancy: causes and management

  2019cites this paper
• Diagnosis, Pathophysiology and Management of Hypercalcemia in Malignancy: A Review of the Literature

  2019cites this paper
• Outcomes of hypercalcemia of malignancy in patients with solid cancer: a national inpatient analysis

  2019cites this paper
• Retrospective chart evaluation of hypercalcemia management in oncology patients at the University of Chicago Medical Center

  2019cites this paper
• Inhibition of the fibrillation of highly amyloidogenic human calcitonin by cucurbit[7]uril with improved bioactivity.

  2018cites this paper
• A novel alendronate functionalized nanoprobe for simple colorimetric detection of cancer-associated hypercalcemia.

  2018cites this paper
• Double Trouble – Severe Hypernatremia Secondary to Central Diabetes Insipidus Complicated by Hypercalcemic Nephrogenic Diabetes Insipidus: A Case Report

  2018cites this paper
• Malignancy-Related Hypercalcemia in Advanced Solid Tumors: Survival Outcomes

  2017cites this paper
• Animal Models of Cancer-Associated Hypercalcemia

  2017cites this paper
• The Changing Profile of Hypercalcemia in Hospital Populations

  2017cites this paper
• Hypercalcemia of malignancy treated with cinacalcet

  2017cites this paper
• Association of calcium sensing receptor polymorphisms at rs1801725 with circulating calcium in breast cancer patients

  2017cites this paper
• Hypercalcaemia and hypocalcaemia: finding the balance

  2017cites this paper
• Protocolo diagnóstico y terapéutico de la hipercalcemia en el enfermo oncológico

  2017cites this paper
• Prevalence of hypercalcemia of malignancy among pediatric cancer patients in the UK Clinical Practice Research Datalink database

  2017cites this paper
• Diagnosis and Management of Lung Cancer, 3rd ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines

  2017cites this paper
• Editorial: Adjuvant Systemic Treatment Strategy for Early Breast Cancer.

  2016cites this paper
• Complete resolution of refractory hypercalcemia following pneumonectomy in squamous cell carcinoma of the lung

  2016cites this paper
• Serum calcium, albumin and tumor stage in cutaneous malignant melanoma.

  2016cites this paper
• Prevalence of hypercalcemia among cancer patients in the United States

  2016cites this paper
• Gene environment interaction in periphery and brain converge to modulate behavioral outcomes: Insights from the SP1 transient early in life interference rat model

  2016cites this paper
• Bone turnover markers in women with early stage breast cancer who developed bone metastases. A prospective study with multivariate logistic regression analysis of accuracy.

  2016cites this paper
• Risk Factors for Developing Skeletal-Related Events in Breast Cancer Patients With Bone Metastases Undergoing Treatment With Bone-Modifying Agents.

  2016cites this paper
• Interspecialty Differences in Physicians' Attitudes, Beliefs, and Reasons for Withdrawing or Withholding Hypercalcemia Treatment in Terminally Ill Patients

  2016cites this paper
• Refractory Hypercalcemia in a Jamaican Woman

  2016influential citation
• Adjuvant Hormonal Therapy in Women with Early-stage Breast Cancer.

  2016cites this paper
• Quality and Outcomes of Treatment of Hypercalcemia of Malignancy

  2015cites this paper
• Prevalence of hypercalcemia of malignancy among cancer patients in the UK: analysis of the Clinical Practice Research Datalink database.

  2015cites this paper
• Denosumab: a new agent in the management of hypercalcemia of malignancy.

  2015cites this paper
• The role of denosumab in the prevention of hypercalcaemia of malignancy in cancer patients with metastatic bone disease.

  2015cites this paper
• Denosumab Therapy for Refractory Hypercalcemia Secondary to Squamous Cell Carcinoma of Skin in Epidermolysis Bullosa

  2015cites this paper
• Acute Management of Hypercalcemia

  2015cites this paper
• Denosumab for Breast Cancer with Bone Metastases-Induced Hypercalcemia Complicated with Acute Renal Failure

  2015cites this paper
• Laboratory approaches for the diagnosis and assessment of hypercalcemia

  2015cites this paper
• Parathyroid cancer.

  2015cites this paper
• Denosumab, a RANKL Inhibitor, Induced Osteonecrosis of the Jaw *

  2014cites this paper
• Physicians’ attitude toward recurrent hypercalcemia in terminally ill cancer patients

  2014cites this paper
• Les hypercalcémies malignes: étude rétrospective sur 150 patients

  2014cites this paper
• Rare association between penile squamous cell carcinoma and parathyroid related peptide (PTH-rP) secretion.

  2014cites this paper
• Effect of intravenous hydration in patients receiving bisphosphonate therapy

  2014cites this paper
• RANKL抑制剂地诺塞麦所致颌骨坏死 Denosumab, a RANKL Inhibitor, Induced Osteonecrosis of the Jaw

  2014cites this paper
• Carboxy-terminal telopeptide (CTX) and amino-terminal propeptide (PINP) of type I collagen as markers of bone metastases in patients with non-small cell lung cancer.

  2013cites this paper
• Clinical and organizational factors in the initial evaluation of patients with lung cancer: Diagnosis and management of lung cancer, 3rd ed: American College of Chest Physicians evidence-based clinical practice guidelines.

  2013cites this paper
• A platform for designing hyperpolarized magnetic resonance chemical probes

  2013cites this paper
• Update on clinical and mechanistic aspects of paraneoplastic syndromes

  2013cites this paper
• The management of hypercalcaemia in advanced cancer.

  2013cites this paper
• [The significance of early diagnosis of cancer-related hypercalcaemia].

  2013cites this paper
• Cancer-induced bone disease.

  2013cites this paper
• Molecular insight into substrate recognition and catalysis of Baeyer-Villiger monooxygenase MtmOIV, the key frame-modifying enzyme in the biosynthesis of anticancer agent mithramycin.

  2013cites this paper
• Use of denosumab for renal cell carcinoma-associated malignant hypercalcemia: a case report and review of the literature.

  2013cites this paper
• Targeted therapies in the treatment of breast cancer and localized sarcomas.

  2013cites this paper
• Denosumab and anti-angiogenetic drug-related osteonecrosis of the jaw: an uncommon but potentially severe disease.

  2013cites this paper
• Acute renal failure caused by tumor-induced hypercalcemia successfully treated by denosumab

  2013cites this paper
• Palliative and Supportive Care for Renal Cancer

  2013cites this paper
• Zoledronic acid to prevent and treat cancer metastasis: new prospects for an old drug.

  2013cites this paper
• Denosumab for tumor-induced hypercalcemia complicated by renal failure.

  2012cites this paper
• Die hyperkalzämische Krise in der Intensivmedizin Hypercalcemic crisis in intensive care

  2012cites this paper
• Calcium metabolism and treatment of hypercalcemia.

  2012cites this paper
• Treatment of chronic hypercalcemia.

  2012cites this paper
• Die hyperkalzämische Krise in der Intensivmedizin

  2012cites this paper
• Diagnostic des hypercalcémies « non hyperparathyroïdiennes »

  2012cites this paper
• Treatment of acute hypercalcemia.

  2012cites this paper
• Curcuminoids in the prevention of osteoclast-mediated bone resorption in translational models of postmenopausal osteoporosis and lytic breast cancer bone metastasis

  2012cites this paper
• Diagnosis of alterations of serum calcium metabolism.

  2012cites this paper
• Oncologic emergencies: Pathophysiology, presentation, diagnosis, and treatment

  2011cites this paper
• Serum N-telopeptide of type I collagen and bone alkaline phosphatase and their relationship in patients with non-small cell lung carcinoma and bone metastases. Preliminary results.

  2011cites this paper
• Palliative Care Files

  2011cites this paper
• Evaluation and therapy of hypercalcemia.

  2011cites this paper
• Bone metastases, general and clinical issues.

  2011cites this paper
• Cathepsin L in Normal and Pathological Bone Remodeling

  2011cites this paper
• Cancer-associated hypercalcaemia in squamous-cell malignancies: a survival and prognostic factor analysis.

  2011cites this paper
• Calcium metabolism & hypercalcemia in adults.

  2011cites this paper
• Endocrine therapy of breast cancer.

  2011cites this paper
• Emerging anabolic treatments in osteoporosis.

  2011cites this paper
• Imaging studies in hypercalcemia.

  2011cites this paper
• Mithramycin reduces expression of fibro‐proliferative mRNAs in human gingival fibroblasts

  2011cites this paper
• Cancer-related hypercalcemia.

  2010cites this paper
• Parathyroid cancer.

  2010cites this paper
• Cytokines, thyroid diseases and thyroid cancer.

  2010cites this paper
• L’hypercalcémie reliée au cancer

  2010cites this paper
• Parathyroid hormone‐related peptide‐producing non‐familial pheochromocytoma in a child

  2010cites this paper
• Biochemical markers of particle induced osteolysis in C57BL/6 mice

  2010cites this paper
• New method for calcium on the ADVIA analyzer is free from interference of gadolinium‐type contrast agents

  2009cites this paper
• Denosumab: the era of targeted therapies in bone metastatic diseases.

  2009cites this paper
• Side effects of cancer treatments

  2008cites this paper